基孔肯雅
病毒学
免疫原性
α病毒
虫媒病毒
生物
类病毒颗粒
病毒
抗原性
爆发
免疫学
抗体
重组DNA
遗传学
基因
作者
Danielle Thompson,Stefan Metz,Carmen Abad,Shannon M. Beaty,Kelly L. Warfield
出处
期刊:Vaccine
[Elsevier BV]
日期:2022-04-19
卷期号:40 (22): 3009-3017
被引量:6
标识
DOI:10.1016/j.vaccine.2022.04.021
摘要
Chikungunya virus (CHIKV), an arbovirus from the Alphavirus genus, causes sporadic outbreaks and epidemics and can cause acute febrile illness accompanied by severe long-term arthralgias. Over 20 CHIKV vaccine candidates have been developed over the last two decades, utilizing a wide range of vaccine platforms, including virus-like particles (VLP). A CHIKV VLP vaccine candidate is among three candidates in late-stage clinical testing and has potentially promising data in nonclinical and clinical studies exploring safety and vaccine immunogenicity. Despite the consistency of the CHIKV VLP structure, vaccine candidates vary significantly in protein sequence identity, structural protein expression cassettes and their mode of production. Here, we explore the impact of CHIKV VLP coding sequence variation and the chosen expression platform, which affect VLP expression yields, antigenicity and overall vaccine immunogenicity. Additionally, we explore the potential of the CHIKV VLP platform to be modified to elicit protection against other pathogens.
科研通智能强力驱动
Strongly Powered by AbleSci AI